Researchers at Stanford have developed a dielectric diffraction grating that provides high (near-unity) diffraction efficiencies in an ultra-compact volume.
Researchers at Stanford have developed a highly efficient (>90%) holographic beam steering method for obtaining distance information of objects nearby, with applications from autonomous vehicles to home appliances.
Researchers at Stanford have developed a tunable metasurface with high reflectance and large phase modulation for use as optical phase modulators or beam steering device (Lidar). Currently, the large size of beam steering devices is a critical problem.
Researchers at Stanford have developed a multi-wavelength laser with perpendicular polarization, which supports easy and independent measurement in various optical sensors for improved accuracy and speed.
Genetic engineering of biological systems is a fundamental tool for both basic and translation research, where up- and down-regulation of gene expression is necessary to drive cellular phenotypes and evaluate gene function.
Stanford researchers designed and built a light sheet microscope that can be used for deconvolution-free, high resolution volumetric imaging of cleared tissue specimens.
Researchers at Stanford have developed a method to tune power amplifier circuits to directly connect their output power (and adjust the combined output power) without any additional power combiner network.
This invention involved a new methodology using novel targets, TMS stimulation and a hypnosis protocol to modulate traits and help chronic pain, addiction, and mental disorders.
Polymer electrolyte membrane (PEM) fuel cells often underperform due to high overpotentials caused by sluggish kinetics. Specifically, the Pt-catalyzed oxygen reduction reaction at the cathode renders the energy efficiency well below the thermodynamic limit.
Researchers at Stanford are advancing a new class of nonlinear optical devices that operate with significantly lower energy requirements than previous platforms.
Stanford researchers have applied large-scale proteomic platforms to identify biomarkers that can be used to diagnose uveal melanoma and subtype eye tumors according to their gene expression profile (GEP) class or PRAME status.
Researchers in the Felsher Lab at Stanford University have developed PD-L1 antibody fragment-conjugated nanoparticles to improve upon existing cancer immunotherapies and extend the range of indications to solid tumors.